Anna Mowry - 12 Aug 2021 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CFO and Treasurer
Signature
/s/ Anna Mowry
Issuer symbol
NAUT
Transactions as of
12 Aug 2021
Net transactions value
+$134,925
Form type
4
Filing time
16 Aug 2021, 17:12:52 UTC
Previous filing
09 Jun 2021
Next filing
24 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $134,925 +17,500 $7.71 17,500 12 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $7.60 to $7.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.